Conmed (CNMD) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.92% |
| Dec 31, 2025 | 16.89% |
| Sep 30, 2025 | 59.44% |
| Jun 30, 2025 | -18.31% |
| Mar 31, 2025 | 117.82% |
| Dec 31, 2024 | -18.88% |
| Sep 30, 2024 | 1.51% |
| Jun 30, 2024 | -32.20% |
| Mar 31, 2024 | 10.61% |
| Dec 31, 2023 | 9.19% |
| Sep 30, 2023 | -11.21% |
| Jun 30, 2023 | -16.46% |
| Mar 31, 2023 | 25.59% |
| Dec 31, 2022 | 11.10% |
| Sep 30, 2022 | -53.37% |
| Jun 30, 2022 | 50.31% |
| Mar 31, 2022 | -8.52% |
| Dec 31, 2021 | -47.46% |
| Sep 30, 2021 | -44.53% |
| Jun 30, 2021 | 15.72% |
| Mar 31, 2021 | 17.02% |
| Dec 31, 2020 | -26.69% |
| Sep 30, 2020 | -16.04% |
| Jun 30, 2020 | 31.31% |
| Mar 31, 2020 | -15.34% |
| Dec 31, 2019 | -25.06% |
| Sep 30, 2019 | -0.27% |
| Jun 30, 2019 | -18.46% |
| Mar 31, 2019 | 28.26% |
| Dec 31, 2018 | -34.46% |
| Sep 30, 2018 | -9.67% |
| Jun 30, 2018 | -13.25% |
| Mar 31, 2018 | -27.30% |
| Dec 31, 2017 | -31.73% |
| Sep 30, 2017 | -7.69% |
| Jun 30, 2017 | 29.19% |
| Mar 31, 2017 | 23.81% |
| Dec 31, 2016 | 16.56% |
| Sep 30, 2016 | -28.41% |
| Jun 30, 2016 | -6.01% |
| Mar 31, 2016 | -67.48% |
| Dec 31, 2015 | 33.33% |
| Sep 30, 2015 | -3.23% |